Evaluating and improving diagnostics and management of venous thromboembolism

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The VTEval Project is a prospective observational study aimed at evaluating and improving the diagnostics and management strategies for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). It involves three long-term cohorts of patients with suspected or incident VTE, focusing on systematic assessments of disease status and risk profiles. The study seeks to address the significant public health challenges posed by VTE, particularly in older populations, by collecting comprehensive data on symptoms, clinical factors, and psychosocial aspects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years and Informed written consent
* Clinical condition:

  * Cohort 1: Clinical suspicion of acute PE (with or without DVT)
  * Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE)
  * Cohort 3: Incidentally diagnosed VTE

Where it's running

• University Medical Center of the Johannes Gutenberg University Mainz
  Mainz, Rhineland-Palatinate, Germany Recruiting

Study contacts

• Principal investigator: Philipp S Wild, MD, MSc — University Medical Center of Johannes Gutenberg University Mainz, Germany
• Study coordinator: Philipp S Wild, MD, MSc
• Email: philipp.wild@unimedizin-mainz.de
• Phone: 0049 6131 17 7163

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up

  This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.

  Recruiting at 16 sites Azienda Ospedaliero-Universitaria Careggi · Bagno a Ripoli, Tuscany and 15 other locations · NCT07855679

• Predicting blood clots after lung cancer surgery

  This project will try to use clinical, surgical, and lab data to predict which adults having lung cancer surgery may develop blood clots after the operation.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07439991

• Aspirin vs. rivaroxaban for blood clot prevention in newly diagnosed multiple myeloma

  In newly diagnosed multiple myeloma patients on IMiD-based therapy, this study tests whether aspirin or rivaroxaban is better at preventing blood clots.

  Recruiting Phase 4 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT07907211

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• YKYY033 Injection safety and tolerability in adults

  This study tests whether a single dose of YKYY033 injection is safe and tolerable in healthy adults aged 18–55.

  Recruiting Phase 1 Youcare Pharmaceutical Group Co., Ltd. · Beijing, Beijing Municipality · NCT07786779

• Thrombectomy system to treat leg DVT

  This trial tests a peripheral thrombectomy device to treat lower extremity deep vein thrombosis in adults.

  Recruiting BrosMed Medical Co., Ltd · Shanghai · NCT07749820

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.